Clinical analysis on anti-N-methyl-D-aspartate receptor encephalitis cases: Chinese experience

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 10, 2015, Pages 18927-18935

  Huang, Xiaoqin ^a   Fan, Chunqiu ^a   Wu, Jian ^a   Ye, Jing ^a   Zhan, Shuqin ^a   Song, Haiqing ^a   Liu, Aihua ^a   Su, Yingying ^a   Jia, Jianping ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Anti NMDAR; Chinese population; Clinical manifestations; Treatment

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN;

ADOLESCENT; ADULT; ANTI N METHYL D ASPARTATE RECEPTOR ENCEPHALITIS; ARTICLE; BEHAVIOR DISORDER; CHEMILUMINESCENCE IMMUNOASSAY; CHINESE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONSCIOUSNESS DISORDER; DISEASE ASSESSMENT; DISEASE COURSE; ELECTROENCEPHALOGRAPHY; EPILEPSY; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; HYPOVENTILATION; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; MALE; MENTAL DISEASE; MOTOR DYSFUNCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMAPHERESIS; PROTEIN CEREBROSPINAL FLUID LEVEL; RANKIN SCALE; SEROLOGY; SLEEP DISORDER; TERATOMA;

EID: 84949678836     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Dalmau J, Tuzun E, Wu HY, Masjuan J, Rossi JE, Voloschin A, Baehring JM, Shimazaki H, Koide R, King D, Mason W, Sansing LH, Dichter MA, Rosenfeld MR and Lynch DR. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007; 61: 25-36.
2. Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, Dessain SK, Rosenfeld MR, Balice-Gordon R and Lynch DR. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008; 7: 1091-1098.
3. Florance NR, Davis RL, Lam C, Szperka C, Zhou L, Ahmad S, Campen CJ, Moss H, Peter N, Gleichman AJ, Glaser CA, Lynch DR, Rosenfeld MR and Dalmau J. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol 2009; 66: 11-18.
4. Peery HE, Day GS, Dunn S, Fritzler MJ, Pruss H, De Souza C, Doja A, Mossman K, Resch L, Xia C, Sakic B, Belbeck L and Foster WG. Anti-NMDA receptor encephalitis. The disorder, the diagnosis and the immunobiology. Autoimmun Rev 2012; 11: 863-872.
5. Iizuka T, Sakai F, Ide T, Monzen T, Yoshii S, Iigaya M, Suzuki K, Lynch DR, Suzuki N, Hata T and Dalmau J. Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Neurology 2008; 70: 504-511.
6. Titulaer MJ, McCracken L, Gabilondo I, Armangue T, Glaser C, Iizuka T, Honig LS, Benseler SM, Kawachi I, Martinez-Hernandez E, Aguilar E, Gresa-Arribas N, Ryan-Florance N, Torrents A, Saiz A, Rosenfeld MR, Balice-Gordon R, Graus F and Dalmau J. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 2013; 12: 157-165.
7. Granerod J, Ambrose HE, Davies NW, Clewley JP, Walsh AL, Morgan D, Cunningham R, Zuckerman M, Mutton KJ, Solomon T, Ward KN, Lunn MP, Irani SR, Vincent A, Brown DW, Crowcroft NS; UK Health Protection Agency (HPA) Aetiology of Encephalitis Study Group. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis 2010; 10: 835-844.
8. Xu CL, Liu L, Zhao WQ, Li JM, Wang RJ, Wang SH, Wang DX, Liu MY, Qiao SS and Wang JW. Anti-N-methyl-D-aspartate receptor encephalitis with serum anti-thyroid antibodies and IgM antibodies against Epstein-Barr virus viral capsid antigen: a case report and one year follow-up. BMC Neurol 2011; 11: 149.
9. Song L and Liu AH. [Anti-N-methyl-D-aspartic acid receptor encephalitis: clinical analysis of 7 cases]. Zhonghua Yi Xue Za Zhi 2013; 93: 2508-2510.
10. Guan W, Fu Z, Zhang H, Jing L, Lu J, Zhang J, Lu H, Teng J, Jia Y. Non-tumor-Associated Anti-N-Methyl-d-Aspartate (NMDA) Receptor Encephalitis in Chinese Girls With Positive Anti-thyroid Antibodies. J Child Neurol 2015; 30: 1582-5.
11. Luca N, Daengsuwan T, Dalmau J, Jones K, deVeber G, Kobayashi J, Laxer RM and Benseler SM. Anti-N-methyl-D-aspartate receptor encephalitis: a newly recognized inflammatory brain disease in children. Arthritis Rheum 2011; 63: 2516-2522.
12. Day GS, High SM, Cot B and Tang-Wai DF. Anti-NMDA-receptor encephalitis: case report and literature review of an under-recognized condition. J Gen Intern Med 2011; 26: 811-816.
13. Fairweather D, Frisancho-Kiss S and Rose NR. Viruses as adjuvants for autoimmunity: evidence from Coxsackievirus-induced myocarditis. Rev Med Virol 2005; 15: 17-27.
14. Huerta PT, Kowal C, DeGiorgio LA, Volpe BT and Diamond B. Immunity and behavior: antibodies alter emotion. Proc Natl Acad Sci U S A 2006; 103: 678-683.
15. Iizuka T and Sakai F. [Anti-nMDA receptor encephalitis--clinical manifestations and pathophysiology]. Brain Nerve 2008; 60: 1047-1060.
16. Nasky KM, Knittel DR and Manos GH. Psychosis associated with anti-N-methyl-D-aspartate receptor antibodies. CNS Spectr 2008; 13: 699-703.
17. Wandinger KP, Saschenbrecker S, Stoecker W and Dalmau J. Anti-NMDA-receptor encephalitis: a severe, multistage, treatable disorder presenting with psychosis. J Neuroimmunol 2011; 231: 86-91.
18. Barry H, Hardiman O, Healy DG, Keogan M, Moroney J, Molnar PP, Cotter DR and Murphy KC. Anti-NMDA receptor encephalitis: an important differential diagnosis in psychosis. Br J Psychiatry 2011; 199: 508-509.
19. Bayreuther C, Bourg V, Dellamonica J, Borg M, Bernardin G and Thomas P. Complex partial status epilepticus revealing anti-NMDA receptor encephalitis. Epileptic Disord 2009; 11: 261-265.
20. Ferioli S, Dalmau J, Kobet CA, Zhai QJ, Broderick JP and Espay AJ. Anti-N-methyl-D-aspartate receptor encephalitis: characteristic behavioral and movement disorder. Arch Neurol 2010; 67: 250-251.
21. Stamelou M, Plazzi G, Lugaresi E, Edwards MJ and Bhatia KP. The distinct movement disorder in anti-NMDA receptor encephalitis may be related to Status Dissociatus: a hypothesis. Mov Disord 2012; 27: 1360-1363.
22. Poloni C, Korff CM, Ricotti V, King MD, Perez ER, Mayor-Dubois C, Haenggeli CA and Deonna T. Severe childhood encephalopathy with dyskinesia and prolonged cognitive disturbances: evidence for anti-N-methyl-D-aspartate receptor encephalitis. Dev Med Child Neurol 2010; 52: e78-82.
23. Finke C, Kopp UA, Pruss H, Dalmau J, Wandinger KP and Ploner CJ. Cognitive deficits following anti-NMDA receptor encephalitis. J Neurol Neurosurg Psychiatry 2012; 83: 195-198.
24. Uchino A, Iizuka T, Urano Y, Arai M, Hara A, Hamada J, Hirose R, Dalmau J and Mochizuki H. Pseudo-piano playing motions and nocturnal hypoventilation in anti-NMDA receptor encephalitis: response to prompt tumor removal and immunotherapy. Intern Med 2011; 50: 627-630.
25. Kirkpatrick MP, Clarke CD, Sonmezturk HH and Abou-Khalil B. Rhythmic delta activity represents a form of nonconvulsive status epilepticus in anti-NMDA receptor antibody encephalitis. Epilepsy Behav 2011; 20: 392-394.
26. Gitiaux C, Simonnet H, Eisermann M, Leunen D, Dulac O, Nabbout R, Chevignard M, Honnorat J, Gataullina S, Musset L, Scalais E, Gauthier A, Hully M, Boddaert N, Kuchenbuch M, Desguerre I and Kaminska A. Early electro-clinical features may contribute to diagnosis of the anti-NMDA receptor encephalitis in children. Clin Neurophysiol 2013; 124: 2354-2361.
27. Iizuka T, Yoshii S, Kan S, Hamada J, Dalmau J, Sakai F and Mochizuki H. Reversible brain atrophy in anti-NMDA receptor encephalitis: a long-term observational study. J Neurol 2010; 257: 1686-1691.